Advancing Human Health & Performance

What if wearables could change lives? Orpyx® foot pressure measurement technologies includes wearable sensors used to improve human health and advance sports performance.

SurroSense Rx®

Limb loss isn’t inevitable. Help prevent diabetic foot ulcers and track progress. Get your feet back on track with the SurroSense Rx system.

Orpyx® LogR™

Accurate, efficient, and real-time measurement of foot and plantar pressure analysis. 100% mobile, durable and reusable, no tether, computer or lab required.

Recent News

Orpyx Awarded Federal Supply Schedule (FSS) Contract

Orpyx Medical Technologies Inc. announced today that the National Acquisition Center of the Department of Veterans Affairs has awarded the company a Federal Supply Schedule (FSS) contract available through Academy Medical, LLC (contract number 36F79718D0372), effective April 1, 2018. The awarding of this contract will provide all U.S. federal medical providers, including those operated by the U.S. Department of Veterans Affairs (VA), Department of Defense (DoD) and Indian Health Services (IHS), easy access to SurroSense Rx system.

read more

Cost-effectiveness journal article published

Orpyx Medical Technologies Inc. announced today the publication of “Cost effectiveness of smart insoles in preventing ulcer recurrence for people in diabetic foot remission” in Wound Care Management. The analysis shows the cost-effectiveness of smart insoles as an adjunct to standard diabetic foot care. A pilot study completed at the University of Arizona’s Southern Arizona Limb Salvage Alliance (SALSA) provided clinical inputs for two decision tree models-one at three-months and one at eighteen-months post diabetic foot ulcer (DFU) closure, comparing current standard of care to use of the SurroSense Rx system as an adjunct to standard of care (SOC).

read more

Orpyx Technology Helps Patient with Prevention and Early Detection of Ulceration

Orpyx Medical Technologies Inc. announced today the American Society of Plastic Surgeons published “Novel Pressure-Sensing Smart Insole System Used for the Prevention of Pressure Ulceration in the Insensate Foot Case Report”. This case study explores the use of Orpyx’s SurroSense Rx® system for a patient with spina bifida, history of clubfoot, 20 operations to their right leg, and 3 years of unsuccessful wound management.

read more

Contact Us

U.S. Patent No. 10,004,428 - June 2018
U.S. Patent No. 9,778,131 B2 - October 2017
U.S. Patent No. D740,950 S - October 2015
Australia Patent No. 2011320072 - May 2016
Japan Patent No. 6004444 - October 2016
New Zealand Patent No. 611197 - November 2015

Subscribe to our newsletter
* indicates required